(S (NP-SBJ (NP (NN Costimulation)) (PP (IN of) (NP (NP-COOD (NP (NN cAMP)) (CC and) (NP (NN protein) (NN kinase) (NN C))) (NNS pathways)))) (VP-COOD (VP (VBZ inhibits) (NP (DT the) (JJ CD3-dependent) (NN T) (NN cell) (NN activation))) (CC and) (VP (VBZ leads) (PP (TO to) (NP (NP (DT a) (JJ persistent) (NN expression)) (PP (IN of) (NP (DT the) (NN AP-1) (NN transcription) (NN factor))))))) (. .))
(S (S-COOD (S (NP-SBJ-1 (NP (DT The) (NNS effects)) (VP (VBN mediated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (JJ combined) (NN stimulation)) (PP (IN of) (NP (ADJP-COOD (ADJP (NP (NN cAMP-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (NN protein) (NN kinase) (NN C) (-LRB- -LRB-) (NN PKC) (-RRB- -RRB-) (JJ -dependent))) (NNS pathways))))))) (VP (VBP have) (VP (VBN been) (VP (VBN investigated) (NP (-NONE- *-1)) (PP (IN in) (NP (JJ different) (JJ cellular) (NNS systems))))))) (, ,) (CC and) (S (NP-SBJ (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ-2 (PRP they)) (VP (MD may) (VP (VB complement) (NP (DT each) (JJ other)) (PP (IN in) (S (NP-SBJ (-NONE- *-2)) (VP (VBG activating) (NP (NN cell) (NP-COOD (NP (NN proliferation)) (CC and) (NP (NN differentiation)))))))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP-SBJ (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP-TMP (IN upon) (NP (NP (DT the) (NN stimulation)) (PP (IN of) (NP (DT both) (NNS pathways))))) (NP-SBJ (NN T) (NNS lymphocytes)) (VP (VBD became) (ADJP-PRD (JJ refractory) (PP (TO to) (NP (NP (NN activation)) (PP (IN via) (NP (DT the) (NN (T CD3)) (NN cell) (NN receptor) (-LRB- -LRB-) (NN TcR) (-RRB- -RRB-) (NN complex)))))))))) (. .))
(S-COOD (S (NP-SBJ (NP (NN T) (NNS cells)) (VP (VBN preincubated) (NP (-NONE- *)) (PP (IN with) (NP-COOD (NP (NP (NN phorbol) (NN 12-myristate) (NN 13-acetate)) (PRN (-LRB- -LRB-) (NP (NN PMA)) (-RRB- -RRB-))) (CC and) (NP (NP (NN dibutyryl) (NN cAMP)) (PRN (-LRB- -LRB-) (NP (NN Bt2cAMP)) (-RRB- -RRB-))))))) (VP (VBD displayed) (NP (DT a) (JJ deficient) (JJ proliferative) (NN ability)) (PP (IN in) (NN response) (TO to) (NP (JJ anti-CD3) (NN mAb) (NN stimulation))))) (, ,) (IN whereas) (S (NP-SBJ (NP (NNS lymphocytes)) (VP (VBN treated) (NP (-NONE- *)) (ADVP (RB individually)) (PP (IN with) (NP-COOD (CC either) (NP (NN Bt2cAMP)) (CC or) (NP (NN PMA)))))) (VP (VBD responded) (ADVP (RB comparably)) (PP (TO to) (NP (JJ untreated) (NNS samples))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD detected) (NP (NP (DT an) (NN association)) (PP (IN between) (NP (NP (DT the) (NP-COOD (NP (VBN reduced) (JJ mitogenic) (NN response)) (CC and) (NP (JJ low) (NN expression)))) (PP (IN of) (NP-COOD (CC both) (NP (NP (NN interleukin-2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT the) (NN alpha) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN CD25)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (DT the) (NN IL-2) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN IL-2R)) (-RRB- -RRB-))))))))))) (. .))
(S (NP-SBJ (NP (NN Analysis)) (PP (IN of) (NP (JJ intracellular) (NN Ca2+) (NN mobilization)))) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ-3 (DT the) (JJ (TcR-dependent CD3)) (NN signal) (NN transduction)) (VP (VBD was) (VP (JJ impaired) (NP (-NONE- *-3)) (PP (IN in) (NP (JJ (Bt2cAMP-treated PMA)) (NNS cells)))))))) (. .))
(S-COOD (S (ADVP (RB Remarkably)) (, ,) (NP-SBJ (PRP we)) (VP (VBD observed) (SBAR (IN that) (S (NP-SBJ (DT these) (NNS samples)) (VP (VBD displayed) (NP (NP (DT a) (JJ persistent) (NN expression)) (PP (IN of) (NP (DT the) (NN c-fos) (NN protooncogene))) (, ,) (VP (VBN associated) (NP (-NONE- *)) (PP (TO to) (NP (DT an) (VBN increased) (NN AP-1) (JJ DNA-binding) (NN activity)))))))))) (, ,) (IN whereas) (S (NP-SBJ-4 (NP (DT no) (NNS variations)) (PP (IN of) (NP-COOD (NP (NN CREB)) (CC or) (NP (NN NF-kB))))) (VP (VBD were) (VP (VBN detected) (NP (-NONE- *-4))))) (. .))
(S (NP-SBJ-COOD (CC Neither) (NP (NN Bt2cAMP)) (CC nor) (NP (NN PMA))) (ADVP (RB individually)) (VP (VBD mediated) (NP (NP (DT these) (JJ sustained) (NNS effects)) (, ,) (SBAR (WHNP-5 (WDT which)) (S (NP-SBJ (-NONE- *T*-5)) (ADVP (RB therefore)) (VP (VBP appear) (PP (IN as) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (NP (DT the) (NN interplay)) (PP (IN between) (NP (DT both) (JJ metabolic) (NNS stimuli)))))))))))) (. .))
(S (ADVP (RB Altogether)) (, ,) (NP-SBJ (DT the) (NNS data)) (VP (VBP provide) (NP (DT the) (NN evidence) (SBAR (IN that) (S (NP-SBJ-6 (DT both) (NNS pathways)) (VP-COOD (VP (VBP complement) (NP (DT each) (JJ other)) (PP (IN in) (S (NP-SBJ (-NONE- *-6)) (VP (VBG regulating) (NP (NN gene) (NN expression)))))) (CC and) (VP (ADVP (, ,)) (RB conversely) (, ,) (NP (VBP downregulate) (DT the) (NN TcR) (NN transduction)))))))) (NNS mechanisms))
